Inverse relationship between total testosterone and anti-oxidized low density lipoprotein antibody levels in ageing males

Atherosclerosis

Volumn 164, Issue 2, 2002, Pages 283-288

  Barud, Wojciech ^a   Palusinski, Robert ^a   Beltowski, Jerzy ^a   Woójcicka, Grazyna ^a  

^a MEDICAL UNIVERSITY OF LUBLIN   (Poland)

Author keywords

Anti oxidized LDL antibody; Atherosclerosis; Testosterone

Indexed keywords

AUTOANTIBODY; CHOLESTEROL; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL; OXIDIZED LOW DENSITY LIPOPROTEIN; TESTOSTERONE; TRIACYLGLYCEROL;

ADULT; AGED; AGING; ANTIBODY BLOOD LEVEL; ANTIBODY TITER; ARTICLE; ATHEROGENESIS; BODY MASS; CARDIOVASCULAR RISK; CHOLESTEROL BLOOD LEVEL; CLINICAL ARTICLE; CONTROLLED STUDY; CORONARY ARTERY DISEASE; CORRELATION ANALYSIS; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; IMMUNE RESPONSE; IMMUNOMODULATION; MALE; OXIDATION; PRIORITY JOURNAL; RADIOIMMUNOASSAY; REGRESSION ANALYSIS; SEX HORMONE DETERMINATION; SMOKING; TESTOSTERONE BLOOD LEVEL; TRIACYLGLYCEROL BLOOD LEVEL;

AGED; AGING; AUTOANTIBODIES; BIOLOGICAL MARKERS; CASE-CONTROL STUDIES; CORONARY ARTERIOSCLEROSIS; ENZYME-LINKED IMMUNOSORBENT ASSAY; HUMANS; LIPOPROTEINS, LDL; MALE; MIDDLE AGED; PREDICTIVE VALUE OF TESTS; PROBABILITY; REFERENCE VALUES; REGRESSION ANALYSIS; RISK ASSESSMENT; SAMPLING STUDIES; SENSITIVITY AND SPECIFICITY; STATISTICS, NONPARAMETRIC; TESTOSTERONE;

EID: 0036802944     PISSN: 00219150     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0021-9150(02)00069-2     Document Type: Article

References (49)

1. McNutt R.A., Ferenchick G.S., Kirlin P.C., Hamlin N.J. Acute myocardial infarction in a 22-year-old world class weight lifter using anabolic steroids. Am. J. Cardiol. 62:1988;164.
2. Lenders J.W., Demacker P.N., Vos J.A., Jansen P.L., Hoitsma A.J., van't Laar A., et al. Deleterious effects of anabolic steroids on serum lipoproteins, blood pressure, and liver function in amateur body builders. Int. J. Sports Med. 9:1988;19-23.
3. Ferenchick G.S., Hirokawa S., Mammen E.F., Schwartz K.A. Anabolic-androgenic steroid abuse in weight lifters: evidence for activation of the hemostatic system. Am. J. Hematol. 49:1995;282-288.
4. Zhao S.P., Li X.P. The association of low plasma testosterone level with coronary artery disease in Chinese men. Int. J. Cardiol. 63:1998;161-164.
5. Simon D., Charles M., Nahoul K., et al. Association between plasma total testosterone and cardiovascular risk factors in healthy adult men: the Telecom Study. J. Clin. Endocrinol. Metab. 82:1997;682-685.
6. English K.M., Mandour O., Steeds R.P., Diver M.J., Jones T.H., Channer K.S. Men with coronary artery disease have lower levels of androgens than men with normal coronary angiograms. Eur. Heart J. 21:2000;890-894.
7. Sapin R., Schlienger J.L., Gasser F., Chambron J. Changes in serum testosterone levels after myocardial infarction. J. Nucl. Biol. Med. 36:1992;20-25.
8. Tenover J.S. Effects of testosterone supplementation in the aging male. J. Clin. Endocrinol. Metab. 75:1992;1092-1098.
9. Somjen D., Kohen F., Jaffe A., Amir-Zaltsman Y., Knoll E., Stern N. Effects of gonadal steroids and their antagonists on DNA synthesis in human vascular cells. Hypertension. 32:1998;39-45.
10. Yue P., Chatterjee K., Beale C., Poole-Wilson P.A., Collins P. Testosterone relaxes rabbit coronary arteries and aorta. Circulation. 91:1995;1154-1160.
11. Webb C.M., McNeill J.G., Hayward C.S., de Zeigler D., Collins P. Effects of testosterone on coronary vasomotor regulation in men with coronary heart disease. Circulation. 100:1999;1690-1696.
12. English K.M., Steeds R.P., Jones T.H., Diver M.J., Channer K.S. Low-dose transdermal testosterone therapy improves angina threshold in men with chronic stable angina: a randomized, double-blind, placebo-controlled study. Circulation. 102:2000;1906-1911.
13. Esterbauer H., Wag G., Puhl H. Lipid peroxidation and its role in atherosclerosis. Br. Med. Bull. 49:1993;566-576.
14. Kodama T., Freeman M., Rohrer L., Zabrecky J., Matsudaira P., Krieger M. Type I macrophage scavenger receptor contains alpha-helical and collagen-like coiled coils. Nature. 343:1990;531-535.
15. Witztum J.L. Immunological response to oxidized LDL. Atherosclerosis. 131:1997;S9-S11.
16. Lopes-Virella M.F., Binzafar N., Rackley S., Takei A., La Via M., Virella G. The uptake of LDL-IC by human macrophages: predominant involvement of the Fc gamma RI receptor. Atherosclerosis. 135:1997;161-170.
17. Salonen J.T., Yla-Herttuala S., Yamamoto R., et al. Autoantibody against oxidized LDL and progression of carotid atherosclerosis. Lancet. 339:1992;883-887.
18. Puurunen M., Manttari M., Manninen V., et al. Anibody against oxidized low-density lipoprotein predicting myocardial infarction. Arch. Intern. Med. 154:1994;2605-2609.
19. Sinisalo J., Paronen J., Mattila K.J., et al. Relation of inflammation to vascular function in patients with coronary heart disease. Atherosclerosis. 149:2000;403-411.
20. George J., Ahmed A., Patnaik M., et al. The prediction of coronary atherosclerosis employing artificial neural networks. Clin. Cardiol. 23:2000;453-456.
21. Shoji T., Nishizawa Y., Fukumoto M., et al. Inverse relationship between circulating oxidized low density lipoprotein (oxLDL) and anti-oxLDL antibody levels in healthy subjects. Atherosclerosis. 148:2000;171-177.
22. Lie R.F., Schmitz J.M., Pierre K.J., Gochman N. Cholesterol oxidase-based determination, by continuous-flow analysis, of total and free cholesterol in serum. Clin. Chem. 22:1976;1627-1630.
23. McGowan M.W., Artiss J.D., Strandberrgh D.R., Zak B. A peroxidase-coupled method for the colorimetric determination of serum triglycerides. Clin. Chem. 29:1983;538-542.
24. Friedewald W.T., Levy R.I., Fredrickson D.S. Estimation of the concentration of low-density lipoprotein cholesterol in plasma without use of the preparation ultracentrifuge. Clin. Chem. 18:1972;499-502.
25. Wu R., de Faire U., Lemne C., Witztum J.L., Frostegard J. Autoantibodies to oxLDL are decreased in individuals with borderline hypertension. Hypertension. 33:1999;53-59.
26. Maggi E., Marchesi E., Ravetta V., Martignoni A., Finardi G., Bellomo G. Presence of autoantibodies against oxidatively modified low-density lipoprotein in essential hypertension: a biochemical signature of an enhanced in vivo low-density lipoprotein oxidation. J. Hypertens. 13:1995;129-138.
27. Heitzer T., Yla-Herttuala S., Luoma J., et al. Cigarette smoking potentiates endothelial dysfunction of forearm resistance vessels in patients with hypercholesterolemia. Role of oxidized LDL. Circulation. 93:1996;1346-1353.
28. Marangon K., Herbeth B., Artur Y., Esterbauer H., Siest G. Low and very low density lipoprotein composition and resistance to copper-induced oxidation are not notably modified in smokers. Clin. Chim. Acta. 265:1997;1-12.
29. Adam O., Lemmen C., Kless T., Adam P., Denzlinger C., Hailer S. Low fat diet decreases alpha-tocopherol levels, and stimulates LDL oxidation and eicosanoid biosynthesis in man. Eur. J. Med. Res. 1:1995;65-71.
30. Hartman T.J., Dorgan J.F., Woodson K., et al. Effects of long-term alpha-tocopherol supplementation on serum hormones in older men. Prostate. 46:2001;33-38.
31. Zmuda J.M., Thompson P.D., Winters S.J. Exercise increases serum testosterone and sex hormone-binding globulin levels in older men. Metabolism. 45:1996;935-939.
32. Saarelainen S., Lehtimaki T., Jaak-kola O., Poussa T., Nikkila M., Solakivi T., et al. Autoantibodies against oxidised low-density lipoprotein in patients with obstructive sleep apnoea. Clin. Chem. Lab. Med. 37:1999;517-520.
33. Santamaria J.D., Prior J.C., Fleetham J.A. Reversible reproductive dysfunction in men with obstructive sleep apnoea. Clin. Endocrinol. 28:1988;461-470.
34. Barrett-Connor E., Von Muhlen D.G., Kritz-Silverstein D. Bioavailable testosterone and depressed mood in older men: the Rancho Bernardo Study. J. Clin. Endocrinol. Metab. 84:1999;573-577.
35. Haffner S.M., Mykkänen L., Valdez R.A., Katz M.S. Relationship of sex hormones to lipids and lipoproteins in non-diabetic men. J. Clin. Endocrinol. Metab. 77:1993;1610-1615.
36. Zhou X., Paulsson G., Stemme S., Hansson G.K. Hypercholesterolemia is associated with a T helper (Th) 1/Th2 switch of the autoimmune response in atherosclerotic apo E-knockout mice. J. Clin. Invest. 101:1998;1717-1725.
37. Steinberg D., Parthasarathy S., Carew T.E., Khoo J.C., Witztum J.L. Beyond cholesterol. Modifications of low-density lipoprotein that increase its atherogenicity. N. Engl. J. Med. 320:1989;915-924.
38. Heinecke J.W., Rosen H., Chait A. Iron and copper promote modification of low density lipoprotein by human arterial smooth muscle cells in culture. J. Clin. Invest. 74:1984;1890-1894.
39. Morel D.W., DiCorleto P.E., Chisolm G.M. Endothelial and smooth muscle cells alter low density lipoprotein in vitro by free radical oxidation. Arteriosclerosis. 4:1984;357-364.
40. Huber S.A., Kupperman J., Newell M.K. Estradiol prevents and testosterone promotes Fas-dependent apoptosis in CD4+ Th2 cells by altering Bcl 2 expression. Lupus. 8:1999;384-387.
41. Danel L., Menouni M., Cohen J.H., Magaud J.P., Lenoir G., Revillard J.P., et al. Distribution of androgen and estrogen receptors among lymphoid and haemopoietic cell lines. Leuk. Res. 9:1985;1373-1378.
42. Chao T.C., Van Alten P.J., Walter R.J. Steroid sex hormones and macrophage function: modulation of reactive oxygen intermediates and nitrite release. Am. J. Reprod. Immunol. 32:1994;43-52.
43. Friedl R., Brunner M., Moeslinger T., Spieckermann P.G. Testosterone inhibits expression of inducible nitric oxide synthase in murine macrophages. Life Sci. 68:2000;417-429.
44. Marin J., Rodriguez-Martinez M.A. Nitric oxide, oxygen-derived free radicals and vascular endothelium. J. Auton. Pharmacol. 15:1995;279-307.
45. Bekesi G., Kakucs R., Varbiro S., Racz K., Sprintz D., Feher J., et al. In vitro effects of different steroid hormones on superoxide anion production of human neutrophil granulocytes. Steroids. 65:2000;889-894.
46. Ahlbom E., Prins G.S., Ceccatelli S. Testosterone protects cerebellar granule cells from oxidative stress-induced cell death through a receptor mediated mechanism. Brain Res. 892:2001;255-262.
47. Benten W.P., Lieberherr M., Giese G., et al. Functional testosterone receptors in plasma membranes of T cells. FASEB J. 13:1999;123-133.
48. Giron-Gonzalez J.A., Moral F.J., Elvira J., Garcia-Gil D., Guerrero F., Gavilan I., et al. Consistent production of a higher TH1:TH2 cytokine ratio by stimulated T cells in men compared with women. Eur. J. Endocrinol. 143:2000;31-36.
49. Gomes F., Ruiz P., Lopez R., Rivera C., Romero S., Bernal J.A. Effects of androgen treatment on expression of macrophage Fcgamma receptors. Clin. Diag. Lab. Immunol. 7:2000;682-686.